Cargando…

Association between the size of healthcare facilities and the intensity of hypertension therapy: a cross-sectional comparison of prescription data from insurance claims data

Hypertension is a heterogeneous disease for which role sharing in treatment between specialized facilities and small clinics is needed for efficient healthcare provision. However, the Japanese healthcare system has a “free access” attribute; therefore, nobody can control treatment resource allocatio...

Descripción completa

Detalles Bibliográficos
Autores principales: Hiragi, Shusuke, Sato, Noriaki, Uchino, Eiichiro, Kuroda, Tomohiro, Yanagita, Motoko
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Singapore 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7872892/
https://www.ncbi.nlm.nih.gov/pubmed/32934368
http://dx.doi.org/10.1038/s41440-020-00549-2
_version_ 1783649278152933376
author Hiragi, Shusuke
Sato, Noriaki
Uchino, Eiichiro
Kuroda, Tomohiro
Yanagita, Motoko
author_facet Hiragi, Shusuke
Sato, Noriaki
Uchino, Eiichiro
Kuroda, Tomohiro
Yanagita, Motoko
author_sort Hiragi, Shusuke
collection PubMed
description Hypertension is a heterogeneous disease for which role sharing in treatment between specialized facilities and small clinics is needed for efficient healthcare provision. However, the Japanese healthcare system has a “free access” attribute; therefore, nobody can control treatment resource allocation. We aimed to describe the current situation of role sharing by comparing antihypertensive therapies among different types of medical facilities. We analyzed 1% sampled Japanese medical insurance claims data related to outpatient care as of October 2014. We divided the target patients into four groups according to the size of the facilities that issued the insurance claim for them. Among these groups, we compared the number of antihypertensive drugs and proportion of difficult-to-treat hypertensive cases and performed a stratified analysis. The proportion of patients with hypertension and diabetes mellitus receiving renin-angiotensin-aldosterone system inhibitors (RAASis) as the first-choice drug was also compared. We identified 3465, 1797, 2323, and 34,734 claims issued from large, medium-sized, small hospitals, and clinics, respectively. The mean number of hypertensive drugs was 1.96, 1.87, 1.81, and 1.69, respectively, and the proportion of difficult-to-treat hypertensive cases was 18.9, 17.0, 14.3, and 12.0%, respectively, with both showing significant differences. Stratified analysis showed similar results. The proportion of patients with hypertension and diabetes mellitus receiving RAASis as the first-choice drug was higher in large hospitals than in clinics. In conclusion, facility size is positively associated with the number of antihypertensive drugs and proportions of difficult-to-treat hypertensive cases. This finding describes the current role sharing situation of hypertension therapy in the Japanese healthcare system with a “free-access” attribute.
format Online
Article
Text
id pubmed-7872892
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Springer Singapore
record_format MEDLINE/PubMed
spelling pubmed-78728922021-02-18 Association between the size of healthcare facilities and the intensity of hypertension therapy: a cross-sectional comparison of prescription data from insurance claims data Hiragi, Shusuke Sato, Noriaki Uchino, Eiichiro Kuroda, Tomohiro Yanagita, Motoko Hypertens Res Article Hypertension is a heterogeneous disease for which role sharing in treatment between specialized facilities and small clinics is needed for efficient healthcare provision. However, the Japanese healthcare system has a “free access” attribute; therefore, nobody can control treatment resource allocation. We aimed to describe the current situation of role sharing by comparing antihypertensive therapies among different types of medical facilities. We analyzed 1% sampled Japanese medical insurance claims data related to outpatient care as of October 2014. We divided the target patients into four groups according to the size of the facilities that issued the insurance claim for them. Among these groups, we compared the number of antihypertensive drugs and proportion of difficult-to-treat hypertensive cases and performed a stratified analysis. The proportion of patients with hypertension and diabetes mellitus receiving renin-angiotensin-aldosterone system inhibitors (RAASis) as the first-choice drug was also compared. We identified 3465, 1797, 2323, and 34,734 claims issued from large, medium-sized, small hospitals, and clinics, respectively. The mean number of hypertensive drugs was 1.96, 1.87, 1.81, and 1.69, respectively, and the proportion of difficult-to-treat hypertensive cases was 18.9, 17.0, 14.3, and 12.0%, respectively, with both showing significant differences. Stratified analysis showed similar results. The proportion of patients with hypertension and diabetes mellitus receiving RAASis as the first-choice drug was higher in large hospitals than in clinics. In conclusion, facility size is positively associated with the number of antihypertensive drugs and proportions of difficult-to-treat hypertensive cases. This finding describes the current role sharing situation of hypertension therapy in the Japanese healthcare system with a “free-access” attribute. Springer Singapore 2020-09-15 2021 /pmc/articles/PMC7872892/ /pubmed/32934368 http://dx.doi.org/10.1038/s41440-020-00549-2 Text en © The Author(s) 2020 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.
spellingShingle Article
Hiragi, Shusuke
Sato, Noriaki
Uchino, Eiichiro
Kuroda, Tomohiro
Yanagita, Motoko
Association between the size of healthcare facilities and the intensity of hypertension therapy: a cross-sectional comparison of prescription data from insurance claims data
title Association between the size of healthcare facilities and the intensity of hypertension therapy: a cross-sectional comparison of prescription data from insurance claims data
title_full Association between the size of healthcare facilities and the intensity of hypertension therapy: a cross-sectional comparison of prescription data from insurance claims data
title_fullStr Association between the size of healthcare facilities and the intensity of hypertension therapy: a cross-sectional comparison of prescription data from insurance claims data
title_full_unstemmed Association between the size of healthcare facilities and the intensity of hypertension therapy: a cross-sectional comparison of prescription data from insurance claims data
title_short Association between the size of healthcare facilities and the intensity of hypertension therapy: a cross-sectional comparison of prescription data from insurance claims data
title_sort association between the size of healthcare facilities and the intensity of hypertension therapy: a cross-sectional comparison of prescription data from insurance claims data
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7872892/
https://www.ncbi.nlm.nih.gov/pubmed/32934368
http://dx.doi.org/10.1038/s41440-020-00549-2
work_keys_str_mv AT hiragishusuke associationbetweenthesizeofhealthcarefacilitiesandtheintensityofhypertensiontherapyacrosssectionalcomparisonofprescriptiondatafrominsuranceclaimsdata
AT satonoriaki associationbetweenthesizeofhealthcarefacilitiesandtheintensityofhypertensiontherapyacrosssectionalcomparisonofprescriptiondatafrominsuranceclaimsdata
AT uchinoeiichiro associationbetweenthesizeofhealthcarefacilitiesandtheintensityofhypertensiontherapyacrosssectionalcomparisonofprescriptiondatafrominsuranceclaimsdata
AT kurodatomohiro associationbetweenthesizeofhealthcarefacilitiesandtheintensityofhypertensiontherapyacrosssectionalcomparisonofprescriptiondatafrominsuranceclaimsdata
AT yanagitamotoko associationbetweenthesizeofhealthcarefacilitiesandtheintensityofhypertensiontherapyacrosssectionalcomparisonofprescriptiondatafrominsuranceclaimsdata